Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Carrer Sant Llorenç 21, 43201 Reus, Spain.
Mycopathologia. 2011 Mar;171(3):171-5. doi: 10.1007/s11046-010-9364-8. Epub 2010 Sep 18.
Using a murine model of disseminated infection by two strains of Fusarium verticillioides, we have evaluated the efficacy of high doses of amphotericin B (AMB) (3 mg/kg of body weight/day), voriconazole (VRC) (60 mg/kg of body weight/day), posaconazole (PSC) (100 mg/kg of body weight/day), and the combinations of AMB plus VRC or PSC. In general, our results were very modest. Neither combination was superior to the respective monotherapies. VRC alone and in combination with AMB was able to prolong survival but not to reduce tissue burden, and AMB plus PSC was able to reduce fungal load in organs but not to prolong survival.
我们使用两种伏革菌素(Fusarium verticillioides)菌株播散感染的小鼠模型,评估了高剂量两性霉素 B(AMB)(3 毫克/千克体重/天)、伏立康唑(VRC)(60 毫克/千克体重/天)、泊沙康唑(PSC)(100 毫克/千克体重/天)以及 AMB 加 VRC 或 PSC 联合治疗的疗效。总的来说,我们的结果非常有限。联合治疗并不优于单独用药。单独使用 VRC 和与 AMB 联合使用均可延长存活时间,但不能减轻组织负担,而 AMB 加 PSC 可降低器官中的真菌负荷,但不能延长存活时间。